Receptorpharma Inc

ReceptorPharma has the goal to develop new Alzheimer’s drugs through a completely new pathway and mechanism. We are utilizing the very latest research and findings regarding disease-coupled genes and combining it with the usage of one of the most well-studied drug target protein families. This novel approach to create a new generation of Alzheimer’s disease drugs that act through is our competitive advantage and where our competences shine. In addition to Alzheimer’s disease, our approach will allow for the development of new drugs for several additional debilitating diseases, including certain types of cancer, through similar mechanisms using disease-coupled as drug targets.